PERSONAL Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.
Current molecular imaging modalities face barriers to clinical implementation, providing a need for an improved clinical molecular imaging approach. We hypothesize that EGFR-targeted perfluorocarbon nanodroplets can label metastatic cells; they can then be activated (i.e., converted to a microbubble) and imaged using ultrasound in order to provide a molecular contrast agent that can inform treatment. Pulse sequences were developed for the Verasonics Vantage 128 system to activate and image dodecafluoropentane and dodecafluorohexane nanodroplets. Dodecafluoropentane nanodroplets provided 28-dB enhancement when imaged with pulse-inversion US in a tissue-mimicking environment, while dodecafluorohexane nanodroplets showed activation and subsequent recondensation, allowing for super-resolution imaging.
PERSONAL Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.
The alert did not successfully save. Please try again later.
Trevor Mitcham, Dmitry Nevozhay, Aaron Schwartz-Duval, Stephen Lai, Konstantin Sokolov, Richard Bouchard, "High-frequency ultrasound imaging of targeted, acoustically activated high-contrast Perfluorocarbon Nanodroplets (Conference Presentation)," Proc. SPIE 11319, Medical Imaging 2020: Ultrasonic Imaging and Tomography, 113190Q (27 March 2020); https://doi.org/10.1117/12.2549324